Doc M New Patients welcome. Same-day urgent appointments are available. Dr. Tetyana Metyk, Board Certified Dr. Metyk treats patients like family.

If you are in need of a general doctor/internist Dr. Tetyana Metyk is the Doctor for you. You will always see the Doctor. She has an onsite laboratory, conveniently you do not have to leave the office to obtain laboratory results. She also provides weight loss treatments, medical ma*****na cards, as well as regenerative medicine.

🌟 Non-Invasive Body Contouring Process Explained 🌈Say goodbye to stubborn fat with our non-invasive body contouring trea...
05/24/2023

🌟 Non-Invasive Body Contouring Process Explained 🌈
Say goodbye to stubborn fat with our non-invasive body contouring treatments! These innovative procedures target specific areas, helping you achieve a more sculpted and toned appearance without surgery. Our skilled technicians use cutting-edge technologies to deliver outstanding results. Discover a new level of confidence with our safe and effective body contouring treatments! 🌸✨


























Here's a valuable nutritional advice for weight loss: : Drinking an adequate amount of water throughout the day helps to...
05/22/2023

Here's a valuable nutritional advice for weight loss:
: Drinking an adequate amount of water throughout the day helps to boost metabolism, control hunger, and promote overall health. Aim for at least 8 glasses of water per day.
: Focus on consuming whole, unprocessed foods such as fruits, vegetables, lean proteins, whole grains, and healthy fats. These foods are rich in nutrients, fiber, and can help you feel satisfied for longer.
: Pay attention to portion sizes and avoid mindless eating. Use smaller plates and bowls to help control portion sizes and listen to your body's hunger and fullness cues.
: Slow down and savor each bite. Practice mindful eating by being present while you eat, paying attention to the flavors and textures of your food. This can help prevent overeating and promote better digestion.
: Include a balance of carbohydrates, proteins, and fats in each meal. Carbohydrates provide energy, proteins aid in muscle repair and growth, and healthy fats support satiety and nutrient absorption.
: Minimize your intake of sugary beverages, processed snacks, and desserts. Opt for natural sweeteners like fruits or small amounts of honey or maple syrup when needed.
: Stick to a regular eating schedule and avoid skipping meals. Fuel your body with nourishing meals and healthy snacks throughout the day to keep your metabolism steady and prevent excessive hunger.
: Pay attention to how different foods make you feel. Everyone's nutritional needs and tolerances are unique, so it's important to listen to your body and make adjustments accordingly.
Remember, sustainable weight loss involves making long-term lifestyle changes. Consult with a registered dietitian or healthcare professional for personalized advice and support on your weight loss journey.

🌟 We are excited to offer a medically supervised weight loss program under Dr. Tetyana Metyk, our Internal Medicine Boar...
05/19/2023

🌟 We are excited to offer a medically supervised weight loss program under Dr. Tetyana Metyk, our Internal Medicine Board Certified physician. We offer semaglutide, Wegovi, and tirzepatide -based weight loss plans and other services.


⚡️ Ready to transform your life? We're here to help! ⏰✨ Our weight loss clinic offers personalized programs tailored to your specific needs. With a focus on long-term success, we provide comprehensive support to guide you on your weight loss journey. Our team of experts will create a customized weight loss plan just for you, incorporating the latest medications like Semaglutide and Mic B12. Start your journey today and achieve the results you deserve!


Don't wait any longer to take charge of your health. Contact Dr. Tetyana Metyk and let's work together towards your weight loss goals.

(941)613-1919

📞💚

Happy Mother’s Day
05/14/2023

Happy Mother’s Day

11/06/2021

Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.

Currently most COVID-19 treatments require an IV or injection. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on Thursday the United Kingdom became the first country to OK it.

Pfizer said it will ask the FDA and international regulators to authorize its pill as soon as possible, after independent experts recommended halting the company’s study based on the strength of its results. Once Pfizer applies, the FDA could make a decision within weeks or months.

11/05/2021

Clinical Data Supporting the baricitinib EUA for COVID-19
Baricitinib is authorized for use under an Emergency Use Authorization (EUA) for treatment of coronavirus disease 2019 (COVID-19) in hospitalized adults and pediatric patients 2 years of age or older requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).1

Baricitinib has not been approved for the treatment of COVID-19, but has been authorized for emergency use by the FDA.

Baricitinib is authorized under an EUA only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of baricitinib under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization revoked sooner.

For information on the authorized use of baricitinib and mandatory requirements under the EUA, please review the FDA Letter of Authorization, Fact Sheet for Healthcare Providers, Fact Sheet for Patients, Parents and Caregivers (English) and Fact Sheet for Patients, Parents and Caregivers (Spanish).

Under the EUA, baricitinib is available as 1 mg and 2 mg tablets.

11/05/2021

Merck's antiviral pill that fights COVID-19 in adults with the disease won its first authorization in the world Thursday, as the U.K.'s medical regulator announced that the drug is "safe and effective at reducing the risk of hospitalization and death" in mild to moderate cases.

The drug is a "game changer," British Health and Social Care Secretary Sajid Javid said. Merck and Ridgeback Biotherapeutics developed the oral antiviral.

"Today is a historic day for our country, as the U.K. is now the first country in the world to approve an antiviral that can be taken at home for COVID-19," Javid said.

The U.K.'s authorization is based on clinical studies that showed the drug reduced the risk of hospitalization or death by about 50% for at-risk adults with mild to moderate COVID-19 cases.

The drug, which is called molnupiravir and will be sold under the name Lagevrio in the U.K., helps people cope with COVID-19 by interfering with the virus's ability to replicate itself.

"This prevents it from multiplying, keeping virus levels low in the body and therefore reducing the severity of the disease," the U.K.'s Medicines and Healthcare products Regulatory Agency, or MHRA, said.

10/29/2021

Interesting read.
A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing drugs that could be repurposed to treat coronavirus.

Researchers tested the pill used for depression and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.

They’ve shared the results with the U.S. National Institutes of Health, which publishes treatment guidelines, and they hope for a World Health Organization recommendation.

“If WHO recommends this, you will see it widely taken up,” said study co-author Dr. Edward Mills of McMaster University in Hamilton, Ontario, adding that many poor nations have the drug readily available. “We hope it will lead to a lot of lives saved.”

The pill, called fluvoxamine, would cost $4 for a course of COVID-19 treatment. By comparison, antibody IV treatments cost about $2,000 and Merck’s experimental antiviral pill for COVID-19 is about $700 per course. Some experts predict various treatments eventually will be used in combination to fight the coronavirus.

10/28/2021

Doug Donovan / Published Oct 22
A Johns Hopkins University epidemiologist said Friday that declining COVID-19 cases and hospitalizations in the United States are "great to see," but that a new surge after the holidays is possible if people abandon masking and fail to get vaccinated.

The nearly 531,000 U.S. cases reported this week represents a 13.2% decline from last week, according to an analysis of data from the Johns Hopkins Coronavirus Resource Center. The average daily case count of 76,000 was the lowest since late July but still far higher than the lowest daily average of 11,000 in mid-June. Hospitalizations this week declined nearly 9% over the same period, with intensive care cases falling by 6.7%. The 11,571 deaths reported this week were down by less than 4% from last week.

"I never want to call anything an 'end,' but I certainly welcome the sustained declines in cases we're seeing across the U.S.," said Jennifer Nuzzo, the epidemiology lead for the Coronavirus Resource Center, during the website's expert briefing on Friday. "We're headed in a good direction."

Please join us !!
10/22/2021

Please join us !!

Address

3191 Harbor Boulevard Ste D
Port Charlotte, FL
33952

Opening Hours

Monday 8am - 4:30pm
Tuesday 8am - 4:30pm
Wednesday 8am - 4:30pm
Thursday 8am - 4:30pm
Friday 9am - 3pm

Telephone

+19416131919

Alerts

Be the first to know and let us send you an email when Doc M posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram